Huntington's Disease Clinical Trials Update: February 2024

Advanced search
Browse by:

Department | Year

UCL Theses | Latest

Deposit your research

Huntington's Disease Clinical Trials Update: February 2024

Estevez-Fraga, Carlos; Tabrizi, Sarah J; Wild, Edward J; (2024) Huntington's Disease Clinical Trials Update: February 2024. Journal of Huntington's Disease 10.3233/JHD-240017. (In press). Green open access

Preview

Text
Huntingtons Disease Clinical Trials Update February 2024.pdf - Published Version
Download (727kB) | Preview

Abstract

In this edition of the Huntington's Disease Clinical Trials Update, we expand on the ongoing program from VICO Therapeutics and on the recently terminated VIBRANT-HD clinical trials. We also discuss updates from uniQure's AMT-130 program and PTC therapeutics' trial of PTC518 and list all currently registered and ongoing clinical trials in Huntington's disease.

Type:	Article
Title:	Huntington's Disease Clinical Trials Update: February 2024
Location:	Netherlands
Open access status:	An open access version is available from UCL Discovery
DOI:	10.3233/JHD-240017
Publisher version:	http://doi.org/10.3233/JHD-240017
Language:	English
Additional information:	© 2024 – The authors. Published by IOS Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC 4.0).
Keywords:	Huntington disease, clinical trials
UCL classification:	UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases
URI:	https://discovery.ucl.ac.uk/id/eprint/10189455